Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s Advisory Committee on Immunization Practices on ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...

The Rahway, N.J., drug maker said Friday that its treatment, Keytruda, has been approved for adult patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Martin Kulldorff and Robert Malone, both outspoken vaccine skeptics, have received compensation for their expert ...

Staff who provide data to the vaccine panel have been pushed aside, according to health officials, raising doubts about the ...

Protein deficiency is rare in the United States, but some people are at risk for it. Learn the symptoms of protein deficiency ...

Given that the Australian government heavily subsidizes pharmaceuticals— spending more than $AU16.7 billion annually through ...